The Belgian Diabetes in Pregnancy Follow-up Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

630 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-01-25

Study Completion Date

2023-10-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Gestational diabetes (GDM) is a form of diabetes that develops during pregnancy. GDM is associated with increased risks for pregnancy complications such as macrosomia s and preterm delivery. Women with a history of GDM have a high risk to develop a type 2 diabetes (T2DM) within the next ten years after delivery. The children are also at increased risk of developing obesity and T2DM later in life. Studies are needed to find more accurate predictors for the metabolic risk later in life. This will help to individualize the follow-up and to develop tailored prevention strategies in women and offspring with a history of GDM. In this research project we will therefore investigate how the long-term metabolic risk can more accurately be predicted in a follow-up cohort of the 'Belgian Diabetes in Pregnancy study' (BEDIP-N). We will study the relationship between maternal weight, degree of body fat and degree of hyperglycaemia in pregnancy on the long-term metabolic risk of 375 women and offspring pairs 3-7 years after the delivery across different gestational glucose tolerance groups based on the 2013 WHO criteria in pregnancy. In addition, we will study whether a promising new biomarker, glycated CD59, is a good predictor for the long-term metabolic risk.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Belgian Diabetes in Pregnancy Study: BEDIP-N Study

NCT02036619

Gestational Diabetes Diabetes

COMPLETED

Inter-pregnAncy Coaching for a Healthy fuTure

NCT02989142

Obesity Pregnancy

UNKNOWN NA

Evolution of Maternal Weight During Pregnancy and Influence on the Endothelial Function in Her Offspring

NCT02992106

Endothelial Dysfunction Childhood Obesity

COMPLETED NA

Early PrEgnancy Complications Testing

NCT04079361

Pregnancy Complications

RECRUITING NA

Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk

NCT00550979

Gestational Diabetes Mellitus

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gestational Diabetes Type2 Diabetes Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

GDM

125 mothers with a history of GDM in pregnancy at the time of the BEDIP study and their offspring born during the BEDIP study

GDM

Intervention Type OTHER

different degrees of hyperglycaemia during pregnancy

abnormal GCT group

125 mothers with an abnormal glucose challange test (GCT of 130mg/dl or more) in pregnancy at the time of the BEDIP study and their offspring born during the BEDIP study

No interventions assigned to this group

normal group

125 mothers with both a normal GCT and OGT in pregnancy at the time of the BEDIP study and their offspring born during the BEDIP study

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

GDM

different degrees of hyperglycaemia during pregnancy

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Mothers who participated in the completed BEDIP-N study and received both the GCT as the OGTT during pregnancy
* Offspring born at the time of participation in the BEDIP-N study

Exclusion Criteria

* Mothers:

* Current pregnancy
* Treatment that influences glycaemic status such as high dose corticoids.
* History of bariatric surgery
* gastro-intestinal surgery changing the absorption of glucose (Billroth II)
* A normal study visit will not be possible (incompliance, psychiatric problems…)
* Diagnosed with type 1 diabetes or the presence of auto-immune antibodies for type 1 diabetes

Offspring:

* Treatment that influences glycaemic status such as high dose corticoids.
* A normal study visit will not be possible (incompliance, psychiatric problems…)
* Diagnosed with type 1 diabetes or the presence of auto-immune antibodies for type 1 diabetes

Minimum Eligible Age

3 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No